跳至主要内容
临床试验/NCT03018717
NCT03018717Unknown不适用

Randomized Multicenter Clinical Trial of a Integral Clinical Care Plan Shared With or Without Telemonitoring of Bio Constants in Patients With Chronic Diseases in Advanced Stages. ATLANTIC Project

Fundación Pública Andaluza Progreso y Salud10 个研究点 分布在 1 个国家目标入组 510 人开始时间: 2016年6月13日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
510
试验地点
10
主要终点
Reduce the number of hospital admissions and / or the number of hospital emergency visits and / or the number of primary care visits of the patients in the TELEPAC arm (patients with tele-monitoring) with respect to the PAC arm (patient without tele-Moni

研究概览

简要总结

Information and communications technologies (ICT) currently constitute a key element in the innovation and improvement of providing health-care to frail populations with advanced chronic diseases, but it´s efficacy, safety and cost-effectiveness has not yet been proven conclusively. The investigators are going to carry out a multi-center, randomized, parallel groups, phase III clinical trial in adult patient with heart and/or lung advanced diseases,aiming to analyze the efficacy and cost-efficacy of tele-monitorization of bio-parameters added to optimal standard of clinical care (shared clinical care plan) compared to the shared clinical care plan exclusively.

详细描述

a total number of 510 patients will be divided in 3 centers: Hospital University Virgen del Rocío; Hospital University Virgen Macarena and Public Hospital Comarcal of Serranía de Ronda. Patient will be randomized in Tele-monitoring Constant (TELEPAC) To analyze the efficacy and cost-efficacy of incorporating tele-monitoring of bio-parameters into the shared comprehensive clinical care plan or in Standard Clinical Care (PAC) based on a comprehensive clinical assistance shared between Primary Care and Hospital Care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Majority legal age (18 years of age or older)
  • Present any of the following shortcomings:
  • Heart failure with baseline dyspnea ≥III of New York Heart Association (NYHA) Chronic respiratory insufficiency with basal dyspnea ≥III of Medical Research Council (MRC) Scale and / or oxygen saturation <90% and / or home oxygen therapy.
  • Present Heart Failure or Respiratory Insufficiency with basal dyspnea grade <III (according to NYHA and MRC respectively) but have presented 2 or more income in the last year.
  • Score of Patients with terminal or palliative medical diseases (score PALIAR) index between 0 and 7 points.
  • To present one of the following assistance situations: hospital admission, follow-up in Home Hospitalization or Palliative Care Teams, specialized outpatient follow-up.
  • Speak, understand, read and write Spanish, either the patient or the primary caregiver.
  • Have basic knowledge of the use of mobile phones and applications of computer tablets (such knowledge will be confirmed by personal interview, with test of the device).
  • Informed consent to participate in the study

排除标准

  • Presence of malignant neoplastic disease ACTIVE except localized adenocarcinoma of prostate in hormonal treatment, and / or cutaneous basocellular-squamous cell carcinoma.
  • In the case of Chronic Renal Disease if there is the possibility of entry into Substitutive Therapies (hemodialysis or transplantation)
  • In the case of chronic liver disease, if there is a possibility of liver transplantation.
  • Chronic neurological disease with established cognitive impairment (E. Pfeiffer with 7 or more errors and / or Mild cognitive evaluated (ECM with ≤18 points).
  • Clinical situation of agony.
  • Surprise question ("Would you be surprised if your patient died in the next 6 months?") With the result "I would not be surprised" + PALIAR Score Score ≥7.5 points.
  • Participate in another tele-health initiative.
  • Go simultaneously to a private health service and / or be institutionalized

研究组 & 干预措施

Tele-monitoring Constant

Other

To analyze the efficacy and cost-efficacy of incorporating tele-monitoring of bio-parameters into the shared comprehensive clinical care plan. Patients will receive in their home a kit consisting of a briefcase containing all equipment (scale, pulse-oximeter ... etc) and a logo access to devices (Tablet) through mobile communications m2m between patient and platform Management for Chronic Patients.

干预措施: Telemonitoring Constant (Other)

Standard clinical care

Other

Standard clinical care plan shared between plan of attention to the patient with Pluri-pathological process and the care plan for patients with chronic diseases, based on a comprehensive clinical assistance shared between Primary Care and Hospital Care

干预措施: Standard clinical care (Other)

结局指标

主要结局

Reduce the number of hospital admissions and / or the number of hospital emergency visits and / or the number of primary care visits of the patients in the TELEPAC arm (patients with tele-monitoring) with respect to the PAC arm (patient without tele-Moni

时间窗: Six month

Monitoring number of hospitalizations and/or number of emergency visits in the period.

次要结局

  • Number of hospital admissions(six month)
  • perceived quality and satisfaction with the technological instruments by the subjects in the two arms of the clinical trial.(at 45 days and after 6 months of follow-up,)
  • quality of life related to health, of follow-up in both arms of the clinical trial,(At the time of inclusion, at 45 days and after 6 months of follow-up.)
  • To analyze the secondary incremental cost-effectiveness of the TELEPAC arm with respect to the PAC arm.(six month)
  • Safety by monitoring of adverse events and adverse clinical events related to the two arms of the clinical trial(six month)
  • mortality(six month)
  • Overall cost for patients in euros(six month)
  • quality of care and satisfaction perceived by the subjects in the two arms of the clinical trial.(at 45 days and after 6 months of follow-up)
  • primary cost-effectiveness of the arm TELEPAC with respect to the arm PAC, using the incremental cost method.(six month)
  • Number of admissions-visits to Hospital Emergency(six month)
  • Number of visits to Primary Care Emergencies(six month)
  • Number of days of hospital stay(six month)

研究者

发起方
Fundación Pública Andaluza Progreso y Salud
申办方类型
Other
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验